Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7628720 | 0.98 | SMN1; SMN2 (0.42) | SMN1; SMN2TSHRHIF1ACYP1A1CYP1A2 | |
| SCHEMBL6394555 | 0.89 | ALDH1A1 (0.46) | SMN1; SMN2HIF1ACYP1A1CYP1A2CYP19A1 | |
| SCHEMBL3241768 | 0.86 | NPC1 (0.47) | SMN1; SMN2HIF1ACYP1A2MEN1KMT2A | |
| SCHEMBL7619064 | 0.83 | HIF1A (0.40) | SMN1; SMN2HIF1ACYP1A1CYP1A2CYP19A1 | |
| SCHEMBL2849503 | 0.83 | CYP1A2 (0.41) | SMN1; SMN2TSHRHIF1ACYP1A1CYP1A2 | |
| SCHEMBL18959614 | 0.81 | RXRA (0.45) | SMN1; SMN2HIF1ACYP1A1CYP1A2CYP19A1 | |
| SCHEMBL13242652 | 0.80 | APP (0.54) | SMN1; SMN2RAB9ANPC1CASP3SENP8 | |
| SCHEMBL6388039 | 0.80 | APP (0.54) | SMN1; SMN2RAB9ANPC1CASP3SENP8 | |
| SCHEMBL7627169 | 0.80 | MEN1 (0.67) | SMN1; SMN2TSHRHIF1AFFAR1PPARG | |
| SCHEMBL14341693 | 0.78 | KMT2A (0.43) | SMN1; SMN2TSHRHIF1AFFAR1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9085543-B2 | Polymerizable fullerene derivative and their use in organic photovoltaic cells | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2015-07-21 | — | — | US | disclosed |
| US-9085543-B2 | Polymerizable fullerene derivative and their use in organic photovoltaic cells | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2015-07-21 | — | — | US | disclosed |
| US-20120060926-A1 | POLYMERIZABLE FULLERENE DERIVATIVE AND THEIR USE IN ORGANIC PHOTOVOLTAIC CELLS | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2012-03-15 | — | — | US | disclosed |
| US-20120060926-A1 | POLYMERIZABLE FULLERENE DERIVATIVE AND THEIR USE IN ORGANIC PHOTOVOLTAIC CELLS | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2012-03-15 | — | — | US | disclosed |
| US-6211316-B1 | Taddol and titanium (IV) taddolate dendrimers | NOVARTIS AG (CH) | 2001-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120060926-A1 | POLYMERIZABLE FULLERENE DERIVATIVE AND THEIR USE IN ORGANIC PHOTOVOLTAIC CELLS | S100A10, PIN4, ANXA4 | SMN1; SMN2 4537/4885TSHR 4762/4885HIF1A 4447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.